Increased Serum S100B Protein in Patients with Major Depression

GUO Bin,TAN Yun-Long,YANG Fu-De,ZOU Yi-Zhuang,ZHANG Xiang-Yang,CAO Lian-Yuan,ZHANG Wu-Fang,ZHOU Yu,ZHENG Li-Li,ZHOU Dong-Feng
DOI: https://doi.org/10.3969/j.issn.1000-6729.2009.03.010
2009-01-01
Abstract:Objective: To investigate the relationship of serum S100B protein levels with traits of major depression.Methods: The serum S100B protein levels in 61 major depression patients(depression group,including 19 cases of first-episode,42 cases of recurrence) and 52 healthy volunteers(control group) were examined by enzyme-linked immuno-sorbent assay(ELSIA).The serum S100B levels were compared between the patients with major depression and controls.Depression symptoms were assessed with the Hamilton Depression Rating Scale(HAMD),and the relationships between serum S100B levels and traits of the disorder were analyzed in depression group.Results:(1) The serum S100B level in depression group was significantly higher than that in control group [(0.17±0.10) vs.(0.11±0.04) μg/L;P<0.001].(2) There were no significant differences between first-episode and recurring sub-groups in depression group [(0.15±0.04) vs.(0.17±0.12) μg/L;P=0.430].(3) Serum S100B level was significantly correlated with age of first-episode(r=-0.29,P=0.024) and onset times(r=0.36,P=0.005) in depression group.Conclusion: The serum S100B protein levels in patients with major depression are higher than that in normal control.Serum S100B protein may be a prognosis-related biomarker for major depression.
What problem does this paper attempt to address?